Home
Approach
Portfolio
Team
Community
Community
Impact
Board
University Programs
News & Insights
Pitch Us
Kurome Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KME-0584 for the Treatment of Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS)
Published By :
February 15, 2024
Recent News & Insights
Abre Secures $24 Million Series A Investment to Fuel Growth and Student Impact in K-12 Education
Featured News
·
April 11, 2024
Advancing Data in K-12 Education with Abre
Featured News
·
April 8, 2024
ActionStreamer Technology Showcased By FOX Sports and Tech-Driven UFL During Inaugural Season
Featured News
·
April 4, 2024
More News And Insights
Subscribe TO our newsletter
Stay Up To Date With Our News & Insights
Stay informed with current news about our portfolio companies, events and industry insights.
You are subscribed to our newsletters
Oops! Something went wrong while submitting the form.